Literature DB >> 15688223

[Livid-colored tumor on the scalp].

U W Neisius1, G Schuler, M Lüftl.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15688223     DOI： 10.1007/s00105-004-0858-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  6 in total

Review 1.  Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.

Authors:  Napoleone Ferrara; Kenneth J Hillan; Hans-Peter Gerber; William Novotny
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

2.  Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.

Authors:  F Fata; E O'Reilly; D Ilson; D Pfister; D Leffel; D P Kelsen; G K Schwartz; E S Casper
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

3.  [Cutaneous angiosarcoma].

Authors:  R Fink-Puches; J Smolle; A Beham; H Kerl; H P Soyer
Journal:  Hautarzt       Date:  2000-07       Impact factor: 0.751

Review 4.  Management of angiosarcoma.

Authors:  G Thomas Budd
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

5.  Cutaneous angiosarcoma: a case series with prognostic correlation.

Authors:  Michael B Morgan; Michael Swann; Stephen Somach; William Eng; Bruce Smoller
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

6.  Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.

Authors:  Timothy M Pawlik; Augusto F Paulino; Cornelius J McGinn; Laurence H Baker; Deborah S Cohen; Jeffery S Morris; Riley Rees; Vernon K Sondak
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.